Idiopathic Gastroparesis Clinical Trial
Official title:
Nortriptyline for Idiopathic Gastroparesis: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial (NORIG)
The principal objective of this multicenter, randomized, placebo-controlled trial is to evaluate whether treatment with nortriptyline will improve gastroparesis symptoms compared with placebo.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02232334 -
Effects of Global Osteopathic Manual Treatments in Patients With Idiopathic Gastroparesis
|
N/A | |
Completed |
NCT03544229 -
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
|
Phase 2 | |
Completed |
NCT02732821 -
G-POEM for Treatment of Refractory Gastroparesis
|
||
Completed |
NCT01916460 -
Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients
|
N/A | |
Completed |
NCT01696747 -
Gastroparesis Registry 2
|
||
Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
Completed |
NCT03680859 -
Gastroparesis Registry 3
|
||
Terminated |
NCT01625923 -
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
|
N/A | |
Completed |
NCT03281577 -
Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
|
Phase 2 | |
Enrolling by invitation |
NCT03176927 -
Biomagnetic Characterization of Gastric Dysrhythmias III
|
N/A | |
Recruiting |
NCT04028492 -
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
|
Phase 3 | |
Completed |
NCT04303195 -
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
|
Phase 2 |